RMD 1.05% $37.39 resmed inc

Ann: Resmed to Announce Third Quarter 2015 Results, page-56

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,050 Posts.
    lightbulb Created with Sketch. 1
    Keep calm all - fat price targets are being thrown around.. from CITI $11

    RMD will come back can we go 100% again? Wowee if we can tweak a few things.. all highlighted and discussed

    28/4/2015

    0119 GMT [Dow Jones] New products launched by medical respiratory devices specialist ResMed (RMD.AU) are gaining traction but its margins are under pressure, Citi says. The firm's third-quarter revenue rose 13%, with new products such as its Astral, Air Sense 10 and Air Curve 10 devices doing better than expected. However, Citi notes gross margins were weak at 59.5%. Still, the brokerage reckons the stock is attractive, trading at about 21 times forward earnings. It has a buy recommendation but trims its target to A$11.01/share from A$11.87 after cutting earnings per share forecasts by about 5% and 9% for financial years 2016 and 2017, respectively. RMD is down 2.7% at A$8.23. ([email protected];



    Companies Mentioned

    ResMed Inc RMD:NYS

    Health Care Equipment & Services Sector - Large Cap Stock
 
watchlist Created with Sketch. Add RMD (ASX) to my watchlist
(20min delay)
Last
$37.39
Change
0.390(1.05%)
Mkt cap ! $22.38B
Open High Low Value Volume
$37.30 $37.39 $37.07 $9.449M 253.3K

Buyers (Bids)

No. Vol. Price($)
1 44 $37.32
 

Sellers (Offers)

Price($) Vol. No.
$37.39 2573 2
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
RMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.